FDA Inspection 1286254 — Chongqing Kangle Pharmaceutical Co., Ltd
The FDA completed an inspection of Chongqing Kangle Pharmaceutical Co., Ltd on Sep 5, 2025 in Chongqing. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Sep 5, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Chongqing (China)